脊柱关节炎长期功能恶化与永久性残疾的性别差异:REGISPON-3研究17年随访
基于西班牙REGISPONSER注册队列411例脊柱关节炎患者17年后重评估,女性随访时功能状态更差且功能恶化更显著(ΔBASFI 1.47±2.81 vs 0.38±2.57,p<0.001),但永久性残疾率相似(27.1% vs 32.1%,p=0.31)。bDMARD暴露通过CRP对ΔBASFI的间接效应仅在男性中显著,存在显著性别交互。
要点
- 女性脊柱关节炎患者长期功能恶化程度显著高于男性。
- 两性永久性工作残疾率随访时相似。
- bDMARD经CRP影响功能变化的间接效应仅见于男性。
核心结论
- 女性脊柱关节炎患者尽管随访时永久性工作残疾率与男性相似,但长期功能恶化更显著。
- 全身炎症与长期功能结局的关系可能因性别而异。
研究设计与样本
- 纵向观察性研究,纳入西班牙REGISPONSER注册队列411例脊柱关节炎患者,基线为2004-2007年,17年后于REGISPON-3(2021-2024)重评估。
- 采用性别分层logistic回归和多变量线性回归模型,并以性别为调节变量进行 moderated mediation 分析评估CRP在bDMARD暴露与ΔBASFI关联中的中介作用。
主要发现
- 共纳入271例男性(65.9%)和140例女性(34.1%)脊柱关节炎患者。
- 随访时女性功能状态显著更差且功能恶化更显著(ΔBASFI 1.47±2.81 vs 0.38±2.57,p<0.001)。
- 永久性残疾率两性相似(27.1% vs 32.1%,p=0.31)。
- 更高的BASDAI和BASRI-total在两性中均独立与残疾相关。
- 基线BASFI和BASDAI在两性中均预测ΔBASFI;男性额外预测因素包括BASRI-total和枕墙距,女性中BASRI-column有相关性。
关键数值与推荐
- bDMARD暴露通过CRP对ΔBASFI的间接效应在男性中显著,在女性中不显著,且存在显著性别交互。
临床怎么用
- 临床应关注女性脊柱关节炎患者长期功能恶化的风险,即使残疾率与男性相似。
- bDMARD治疗中炎症控制与功能结局的关系可能需按性别差异化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The primary objective was to assess sex differences in long-term functional deterioration and permanent work disability in spondyloarthritis (SpA), and the secondary aim to evaluate whether systemic inflammation mediates the association between biologic disease-modifying antirheumatic drugs (bDMARDs) exposure and functional change in a sex-dependent manner. METHODS: A longitudinal observational study was conducted in 411 patients with SpA from the Spanish REGISPONSER registry (baseline 2004-2007), who were reassessed 17 years later in REGISPON-3 (2021-2024). Outcomes were Bath Ankylosing Spondylitis Functional Index (BASFI) at follow-up, ΔBASFI and permanent work disability. Sex-stratified logistic and multivariable linear regression models were used. Moderated mediation analysis evaluated C reactive protein (CRP) as a mediator of the association between bDMARD exposure and ΔBASFI, with sex as a moderator. RESULTS: A total of 271 male patients with SpA (65.9%) and 140 female patients with SpA (34.1%) were included. At follow-up, female patients showed significantly worse functional status and greater functional deterioration (ΔBASFI 1.47±2.81 vs 0.38±2.57, p<0.001), whereas permanent disability rates were similar (27.1% vs 32.1%, p=0.31). Higher Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Radiology Index (BASRI)-total were independently associated with disability in both sexes. Baseline BASFI and BASDAI predicted ΔBASFI in both sexes; additional predictors in male patients included BASRI-total and occiput-to-wall distance, whereas BASRI-column was relevant in female patients. The indirect effect of bDMARD exposure on ΔBASFI through CRP was significant in male patients but not in female patients with a significant sex interaction. CONCLUSION: Female patients experienced greater long-term functional deterioration despite similar work disability rates at follow-up. The relationship between systemic inflammation and long-term functional outcomes may differ by sex.
引用
- Moldovan DMM, Ladehesa-Pineda L, Puche-Larrubia MÁ, et al. Sex differences in long-term functional deterioration and permanent disability in spondyloarthritis: a 17-year follow-up from the REGISPON-3 study. RMD Open. 2026. PMID: 42457212. doi:10.1136/rmdopen-2026-007008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。